Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.57 |
| ▸ | THRB | P10828 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | NAAA | Q02083 | 1/20 | 0.50 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10622803 | 1.00 | TSHR (0.57) | TSHRTHRBMEN1KMT2ANAAA | |
| SCHEMBL14478076 | 1.00 | TSHR (0.57) | TSHRTHRBMEN1KMT2ANAAA | |
| SCHEMBL30688243 | 1.00 | TSHR (0.57) | TSHRTHRBMEN1KMT2ANAAA | |
| SCHEMBL11075443 | 1.00 | TSHR (0.57) | TSHRTHRBMEN1KMT2ANAAA | |
| SCHEMBL14478077 | 1.00 | TSHR (0.57) | TSHRTHRBMEN1KMT2ANAAA | |
| SCHEMBL10622800 | 1.00 | TSHR (0.57) | TSHRTHRBMEN1KMT2ANAAA | |
| SCHEMBL8692382 | 1.00 | TSHR (0.57) | TSHRTHRBMEN1KMT2ANAAA | |
| SCHEMBL30583069 | 1.00 | TSHR (0.57) | TSHRTHRBMEN1KMT2ANAAA | |
| SCHEMBL30054741 | 0.97 | TSHR (0.53) | TSHRTHRBMEN1KMT2ANAAA | |
| SCHEMBL14660138 | 0.96 | TSHR (0.50) | TSHRTHRBMEN1KMT2ANAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024175024-A1 | NEW FUSED HETEROCYCLIC COMPOUND AS CDKS INHIBITOR AND USE THEREOF | 杭州德睿智药科技有限公司 | 2024-08-29 | — | — | WO | claimed |
| WO-2024175024-A1 | NEW FUSED HETEROCYCLIC COMPOUND AS CDKS INHIBITOR AND USE THEREOF | 杭州德睿智药科技有限公司 | 2024-08-29 | — | — | WO | disclosed |
| WO-2023102140-A1 | TMPRSS2 INHIBITORS AND METHODS OF USE | TOPSPIN THERAPEUTICS, INC. (US) | 2023-06-08 | — | — | WO | disclosed |
| EP-4118069-A1 | 2,5- OR 2,6-DISUBSTITUTED HYDROQUINONE DERIVATIVES WITH AT LEAST ONE CARBOXY, SULFO OR AMIDO GROUP USEFUL AS MEDICAMENTS | OM Pharma SA (CH) | 2023-01-18 | — | — | EP | disclosed |
| US-4450303-A | IN PRESENCE OF OXYGEN AND SAMARIN SALT | PHILLIPS PETROLEUM COMPANY (US) | 1984-05-22 | — | — | US | disclosed |
| US-4282383-A | FREE RADICAL CATALYST; TERTIARY-BUTYL, CUMENE OR P-DIISOPROPYLBENZENE HYDROPEROXIDE | THE UPJOHN COMPANY (US) | 1981-08-04 | — | — | US | disclosed |